The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
976
June 7, 1996
View Complete Issue         Table of Contents 2019 
Azelaic Acid - A New Topical Drug for Acne
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Azelaic Acid - A New Topical Drug for Acne
June 7, 1996 (Issue: 976)
Azelaic acid, a naturally occurring heptanedicarboxylic acid, has been marketed in the USA as a 20% cream (Azelex - Allergan) for treatment of acne. The drug has been available in Europe for several years.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Azelaic Acid - A New Topical Drug for Acne
Article code: 976b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.